GRAIL to Announce First Quarter 2026 Financial Results
GRAIL (Nasdaq: GRAL) will issue first quarter 2026 financial results after market close on Tuesday, May 5, 2026.
Rhea-AI Summary
GRAIL (Nasdaq: GRAL) will issue first quarter 2026 financial results after market close on Tuesday, May 5, 2026. Management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss results and business progress.
A live webcast and recorded replay will be available at the investor relations site, and registration is requested for the teleconference and webcast to ensure timely connection.
Positive
- None.
Negative
- None.
Details
News Market Reaction – GRAL
In the Apr 23 session, GRAL declined 3.71%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings release date
- May 5, 2026
- Planned Q1 2026 financial results release after market close
- Conference call time PT
- 1:30 p.m. PT
- Scheduled Q1 2026 results webcast and call start time
- Conference call time ET
- 4:30 p.m. ET
- Scheduled Q1 2026 results webcast and call start time
- Join early buffer
- 10 minutes
- Recommended early join time before the scheduled start of the call
Previous Earnings date Reports
-
Announcement of Q4 and full-year 2025 results reporting date and call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
First Quarter 2026 Webcast and Conference Call Details
A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com.
Please register for the live event at https://grail-q1-financial-results-2026.open-exchange.net/.
To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-first-quarter-2026-financial-results-302750644.html
SOURCE GRAIL, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.